Vanda Inc.

Tradipitant shows promise in reducing nausea and vomiting caused by GLP-1 weight-loss treatments.

Study Finds Potential Treatment for GLP-1-Induced Nausea and Vomiting

A new study suggests tradipitant could dramatically reduce the nausea and vomiting that often derail GLP-1 weight-loss treatments, potentially changing how patients tolerate these therapies.